Source: businesswire

APS BioGroup: PanTheryx Invests in the Future Potential of Colostrum with Multiple Acquisitions.

Read full article »
APS BioGroup's Competitors | APS BioGroup's News | APS BioGroup's Financials
Stay up-to-date with the latest news on APS BioGroup
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Andrew Keech's photo - Founder of APS BioGroup

Founder

Andrew Keech

CEO Approval Rating

71/100

Read more
Stay up-to-date with the latest news on APS BioGroup